|
S1378
|
Ruxolitinib (INCB018424) |
INCB018424 is a JAK family inhibitor for JAK1, JAK2 and JAK3 with IC50 of 2.7 nM, 4.5 nM and 322 nM, respectively. |
|
|
|
S5001
|
Tofacitinib citrate (CP-690550 citrate) |
Tofacitinib citrate (CP-690550) is a potent JAK3 inhibitor with IC50 of 1 nM. |
|
|
|
S2736
|
TG101348 (SAR302503) |
TG-101348 (SAR302503) is a selective inhibitor of JAK2 with IC50 of 3 nM. |
|
|
|
S2789
|
Tofacitinib (CP-690550, Tasocitinib) |
CP-690550 is a novel inhibitor of JAK3 with IC50 of 1 nM. |
|
|
|
S2162
|
AZD1480 |
AZD1480 is a novel ATP-competitive inhibitor of JAK1 and JAK2 with IC50 of 1.3 nM and 0.26 nM, respectively. |
|
|
|
S1143
|
AG-490 |
AG-490 (Tyrphostin B42) is an inhibitor of EGFR, ErbB2 and JAK2 with IC50 of 0.1 μM, 13.5 μM, and ~10 μM, respectively. |
|
|
|
S2219
|
Cyt387 |
CYT387 is an ATP-competitive inhibitor of JAK1 and JAK2 with IC50 of 11 nM and 18 nM, respectively. |
|
|
|
S2686
|
NVP-BSK805 |
NVP-BSK805 is a potent and selective ATP-competitive JAK2 inhibitor with IC50 of 0.5 nM. |
|
|
|
S2692
|
TG101209 |
TG101209 is a potent inhibitor of JAK2, Flt3 and RET with IC50 of 6 nM, 25 nM and 17 nM, respectively. |
|
|
|
S2851
|
Baricitinib (LY3009104, INCB28050) |
Baricitinib is a selective JAK1 and JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM, respectively. |
|
|